Sulfasalazine-Induced Epstein-Barr Virus-Positive Mucocutaneous Ulcer

被引：0
|
作者：
Stabel, Cedric [1 ]
Woei-A-Jin, F. J. Sherida H. [2 ]
Tousseyn, Thomas [3 ]
Garmyn, Maria [1 ]
机构：
[1] Univ Hosp Leuven, Dept Dermatol, Leuven, Belgium
[2] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Gen Med Oncol, Leuven, Belgium
[3] Univ Hosp Leuven, Dept Pathol, Leuven, Belgium
来源：
CASE REPORTS IN HEMATOLOGY | 2024年 / 2024卷
关键词：
D O I：
10.1155/2024/6883657
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Epstein-Barr virus (EBV) may cause a wide spectrum of symptomatology in humans ranging from asymptomatic upper respiratory tract infection to infectious mononucleosis and in more severe cases lymphoproliferative disorders or hemophagocytic lymphohistiocytosis. Its neoplastic potential is higher in immunocompromised individuals. We describe a case of EBV-positive mucocutaneous ulcer, a more indolent clinical entity on the spectrum of EBV-driven lymphoproliferative disorders, and are one of the first to put sulfasalazine, an immunomodulatory agent, forward as the possible culprit.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] An Epstein-Barr virus-positive mucocutaneous ulcer in a patient with ulcerative colitis: a recently described entity to take into account
    Parada, Alvaro Yague
    Esteva, Orencio Bosch
    Baron, Daniel Calero
    Fernandez, Andrea Blanco
    Megias, Victor Manuel Castellano
    Vargas, Sara Aurora Rodriguez
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2024, 116 (11) : 645 - 646
  • [32] A case of Epstein-Barr virus-positive mucocutaneous ulcer in the right tongue that disappeared after treatment for oral candidiasis
    Nozato, Tomoyo
    Ozawa, Tomomichi
    Ozawa, Mikio
    Osawa, Kohei
    Hirota, Makoto
    Mitsudo, Kenji
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY MEDICINE AND PATHOLOGY, 2022, 34 (01) : 62 - 65
  • [33] Epstein-Barr Virus-Positive Mucocutaneous Ulcer Mimicking Peri-Implantitis in a Patient With Systemic Lupus Erythematosus
    Takahama Jr, Ademar
    de Lima, Heliton Gustavo
    Ito, Fabio Augusto
    Ribeiro-Silva, Alfredo
    Leon, Jorge Esquiche
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2019, 77 (05) : 977 - 984
  • [34] Successful therapy with interferon alpha-1b for a relapsing Epstein-Barr virus-positive mucocutaneous ulcer
    Xu, Kejia
    Zhao, Sha
    Wang, Tingting
    Tang, Xinyue
    Hua, SiRui
    Chen, Siyu
    Wang, Lin
    JOURNAL OF DERMATOLOGY, 2021, 48 (01): : E3 - E4
  • [35] Cytomorphological Features of Epstein Barr Virus-Related Lymphoproliferative Disorder Associated With Epstein Barr Virus-Positive Mucocutaneous Ulcer
    Szporn, Arnold H.
    Chen, Hua
    Liu, Hui
    Ward, Stephen
    Patel, Kalpesh
    Strauchen, James
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 : A274 - A274
  • [36] Sulfasalazine-induced hypersensitivity syndrome and hemophagocytic syndrome associated with reactivation of Epstein-Barr virus
    Komatsuda, Atsushi
    Okamoto, Yohsuke
    Hatakeyama, Takashi
    Wakui, Hideki
    Sawada, Ken-ichi
    CLINICAL RHEUMATOLOGY, 2008, 27 (03) : 395 - 397
  • [37] Fatal outcome of an Epstein-Barr virus positive mucocutaneous ulcer secondary to methotrexate
    Nakauyaca, A.
    Kalro, A.
    Donaldson, E.
    Patel, H.
    INTERNAL MEDICINE JOURNAL, 2016, 46 (10) : 1226 - 1228
  • [38] Multifocal Epstein-Barr Virus-Positive Mucocutaneous Ulcers in a Patient With Crohn's Disease
    Alphonsus, Lotus
    Zhang, Qi
    Jairath, Vipul
    ACG CASE REPORTS JOURNAL, 2024, 11 (09)
  • [39] HIV-associated anorectal Epstein-Barr virus-positive mucocutaneous ulcer successfully treated with liposomal doxorubicin and rituximab
    Whooley, Peter D.
    Dorer, Russell K.
    Kumar, Anjali S.
    Aboulafia, David M.
    AIDS, 2019, 33 (05) : 929 - 930
  • [40] High prevalence of methotrexate use in patients with Epstein-Barr virus-positive mucocutaneous ulcer may cause confounding bias
    Ramia de Cap, Maximiliano
    Michaels, Phillip D.
    MODERN PATHOLOGY, 2021, 34 (11) : 2084 - 2084
12345